![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
Connect with our experts and industry leaders to uncover strategies to help you achieve more.
Using Data and Analytics to Tackle Drug Pricing Challenges
A groundbreaking solution to help health system customers tackle their 340B program management challenges.
By
Date
June 29, 2022
By: McKesson Health Systems Editorial Team
Read time: 3 minutes
McKesson Health Systems and Macro Helix create game-changing 340B ImpactSM solution
In collaboration with Macro Helix, McKesson Health Systems developed 340B Impact – a groundbreaking solution to help health system customers tackle their 340B program management challenges with the power of data and analytics. The new tool gives healthcare entities unprecedented visibility and insight into their 340B business performance metrics, as well as uncover critical savings opportunities.
The Importance of 340B
The 340B Drug Pricing Program is a federal program to help covered entities provide medications at significantly lower cost to underserved patients. Although this important program provides health systems with a financial safety-net, the 340B Drug Pricing Program is often complicated and difficult to navigate.
To help customers overcome this challenge, McKesson utilized expertise in Health Systems wholesale distribution business and collaborated with Macro Helix, part of McKesson’s Pharmacy Technology & Innovation Group (PTIG) that helps customers manage their 340B program with software and services designed to “uncomplicate the complicated.”
Making an Impact
The idea for 340B Impact began within the 340B Solutions team, which was seeking to innovate with analytics to assist customers. The team created a customized dashboard that could be shared in meetings, delivering valuable insights for the customer. However, they soon realized that allowing customers access to those personalized insights would provide added value for them.
“We knew we could scale it; we just needed the right technology partner,” recalls Chris Shain, Assistant VP, 340B Solutions. “We approached the Macro Helix team, and they were excited because they saw the potential power and value of this for our joint customer base.” Shain joined forces with Brad Stump, Director of Project Management Strategy for Macro Helix to create this cost-saving innovation.
Continued Market Relevance
In April 2022, the solution went live for general availability in the marketplace. But the innovation won’t stop there. 340B Impact will continue to evolve based on customer-centric research, with a focus on how the tool can deliver the most value and enhanced saving opportunities to current customers.
Want to learn more about 340B ImpactSM? Download the Lookbook for more information.
Related Stories
Join us in taking this opportunity to celebrate the contributions of pharmacy technicians, whose training and professionalism support positive outcomes.
McKesson leaders attending a C-Suite dialogue on leveraging ambulatory pharmacy settings.
Explore the value a strategic partnership can bring in helping take your health system pharmacy further to achieve more.
Use this comprehensive library of resources to find important information on what’s changing with 340B and IRA, when, and why it may matter for your health system pharmacy.
Hear part two of LogiPharma’s interview with McKesson Health Systems President Ammie McAsey.
On Women Pharmacist Day, we recognize the unique perspectives and contributions of these critical healthcare professionals.
McKesson Health Systems President Ammie McAsey joins a keynote panel to discuss the growing importance of collaboration across the healthcare ecosystem.
McKesson Health Systems President Ammie McAsey contributes expert insights on how we’re enabling pharmacy to do more for the advancement of patient health.
An interactive experience highlighting key insights for success across 8 domains of specialty pharmacy.